Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.1 | uM | 9 | 625.00 | 320.09 | 776.00 | 795.50 | 0.9755 | 0.9626 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 625.00 | 320.09 | 941.00 | 795.50 | 1.1829 | 1.2729 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 961.00 | 795.50 | 1.2080 | 1.3096 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 320.09 | 773.00 | 795.50 | 0.9717 | 0.9568 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 975.00 | 795.50 | 1.2256 | 1.3351 | |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 625.00 | 320.09 | 1010.00 | 795.50 | 1.2696 | 1.3987 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 625.00 | 320.09 | 319.00 | 795.50 | 0.4010 | -0.0026 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 625.00 | 320.09 | 912.00 | 795.50 | 1.1464 | 1.2193 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 783.00 | 795.50 | 0.9843 | 0.9760 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 625.00 | 320.09 | 273.00 | 795.50 | 0.3432 | -0.1141 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 625.00 | 320.09 | 728.00 | 795.50 | 0.9152 | 0.8694 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 812.00 | 795.50 | 1.0207 | 1.0315 | |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 566.00 | 795.50 | 0.7115 | 0.5434 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 909.00 | 795.50 | 1.1427 | 1.2138 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 320.09 | 839.00 | 795.50 | 1.0547 | 1.0827 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 625.00 | 320.09 | 311.00 | 795.50 | 0.3910 | -0.0217 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 748.00 | 795.50 | 0.9403 | 0.9084 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1674.00 | 1732.50 | 0.9662 | 0.9494 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1764.00 | 1732.50 | 1.0182 | 1.0271 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 684.27 | 1473.00 | 1732.50 | 0.8502 | 0.7719 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1643.00 | 1732.50 | 0.9483 | 0.9224 |
| BT-20 | Erlotinib | 1 | uM | 9 | 1250.00 | 684.27 | 1483.00 | 1732.50 | 0.8560 | 0.7809 |
| BT-20 | Lapatinib | 10 | uM | 9 | 1250.00 | 684.27 | 802.00 | 1732.50 | 0.4629 | 0.1258 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 1751.00 | 1732.50 | 1.0107 | 1.0159 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 684.27 | 1849.00 | 1732.50 | 1.0672 | 1.0995 |